Walking to fight lung cancer: new study tests Exercise's effect on immune cells

NCT ID NCT07267000

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study is testing whether a 12-week home-based walking program can change the immune system in people with lung cancer. Fifty patients will either do moderate continuous walking, high-intensity interval walking, or receive standard exercise advice. Researchers will measure changes in immune cells and chemicals in the blood to see if exercise might help the body fight cancer better.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Home-based walking exercise (moderate continuous or high-intensity interval)
What this could lead to
If this trial shows that exercise changes immune cell activity in lung cancer patients, it could point toward adding exercise as part of standard cancer care to help the immune system fight the disease.
What could go wrong
This is a small, early-stage study (50 people) looking at immune markers, not survival or tumor shrinkage. The results may not translate into a clear treatment benefit or apply to all lung cancer patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for EXERCISE TRAINING are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Medical University of Graz

    RECRUITING

    Graz, 8010, Austria

More trials for these conditions

Other studies related to the condition(s) this trial covers.